Century Therapeutics Inc’s filing revealed that its Chief Operations Officer Farid Adrienne unloaded Company’s shares for reported $1267.0 on Nov 04 ’24. In the deal valued at $1.23 per share,1,033 shares were sold. As a result of this transaction, Farid Adrienne now holds 135,130 shares worth roughly $0.18 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Carr Douglas sold 283 shares, generating $347 in total proceeds. Upon selling the shares at $1.23, the SVP Finance & Operations now owns 317,147 shares.
Before that, Farid Adrienne bought 1,033 shares. Century Therapeutics Inc shares valued at $1,268 were divested by the Officer at a price of $1.23 per share.
Rodman & Renshaw initiated its Century Therapeutics Inc [IPSC] rating to a Buy in a research note published on August 08, 2024; the price target was $6. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in late August from “an Overweight” to “a Neutral”. Chardan Capital Markets began covering IPSC with “Buy” recommendation on December 27, 2022. Guggenheim started covering the stock on October 31, 2022. It rated IPSC as “a Buy”.
Price Performance Review of IPSC
On Tuesday, Century Therapeutics Inc [NASDAQ:IPSC] saw its stock jump 3.85% to $1.35. Over the last five days, the stock has gained 5.47%. Century Therapeutics Inc shares have fallen nearly -59.34% since the year began. Nevertheless, the stocks have fallen -6.25% over the past one year. While a 52-week high of $5.51 was reached on 03/08/24, a 52-week low of $1.14 was recorded on 10/31/24. SMA at 50 days reached $1.4441, while 200 days put it at $2.6206.
Levels Of Support And Resistance For IPSC Stock
The 24-hour chart illustrates a support level at 1.3067, which if violated will result in even more drops to 1.2633. On the upside, there is a resistance level at 1.3867. A further resistance level may holdings at 1.4233. The Relative Strength Index (RSI) on the 14-day chart is 49.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0333, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.39%. Stochastics %K at 23.46% indicates the stock is a holding.
How much short interest is there in Century Therapeutics Inc?
A steep rise in short interest was recorded in Century Therapeutics Inc stocks on 2024-11-15, dropping by -1.07 million shares to a total of 2.26 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 3.33 million shares. There was a decline of -47.19%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 10, 2022 when Canaccord Genuity began covering the stock and recommended ‘”a Buy”‘ rating along with a $28 price target.
